Crossmark

Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

Published Online: 2023-03-30

Published Print: 2023-05

Authors

Ring, Alistair

Karuturi, Meghan

Smyth, Emily Nash

Lokhandwala, Tasneem

Sheffield, Kristin M.

Willey, Joanne

Lunacsek, Orsolya

Sapunar, Francisco

Cui, Zhanglin Lin

Coutinho, Anna

Rybowski, Sarah
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

Text and Data Mining valid from 2023-03-30

Version of Record valid from 2023-03-30
More Information

Article History

Received: 11 November 2022

Accepted: 17 February 2023

First Online: 30 March 2023

Document is current